AIQ Solutions is a commercial-stage imaging biomarker company with offices in Madison, Wisconsin, and Perth, Australia. Built on technology invented at the University of Wisconsin, AIQ provides unique intelligence about heterogeneity of treatment response for patients with complex diseases. AIQ’s biomarkers enable clinicians to make better-informed therapy decisions, improving clinical outcomes and reducing healthcare costs. Supported by published evidence in several late-stage cancers, AIQ’s TRAQinform IQ technology is used by leading researchers and clinicians across the US and Australia. AIQ is a group of passionate entrepreneurs, scientists, and engineers with a vision to improve treatment outcomes for patients with a wide range of complex diseases, all around the world. Leveraging a strong foundation of intellectual property, AIQ is continuously innovating. By combining ingenuity with rigorous clinical validation, AIQ is changing how clinicians manage complex diseases.